+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID07751341

Randomized Phase II Study of SHR-9839 Alone or With Chemotherapy Plus Adebrelimab Compared to Chemotherapy Plus Adebrelimab in Advanced Esophageal Squamous Cell Carcinoma

Led by Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Updated on 2026-09-16

84

Participants Needed

2

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and effectiveness of SHR-9839 given alone or combined with chemotherapy plus adebrelimab in patients with advanced esophageal squamous cell carcinoma ESCC. This phase II, open-label, randomized study aims to compare these treatment options in individuals with this advanced cancer type to better understand their impact. Participants will receive SHR-9839 as a monotherapy or alongside chemotherapy and adebrelimab. The study includes a safety run-in stage with dose adjustments followed by a dose extension stage. Treatments involve SHR-9839 injection, adebrelimab injection, and chemotherapy drugs paclitaxel and cisplatin. The study compares these regimens over approximately one year from the first administration to the end of treatment. During the trial, participants undergo scheduled visits for treatment administration and monitoring. Researchers will assess tumor response rates, duration of relief, disease control, progression-free survival, overall survival, dose-limiting toxicities, maximum tolerated doses, adverse events, and anti-drug antibody development. Safety follow-up and evaluations continue for about one year, with overall survival tracked up to two years, ensuring comprehensive monitoring throughout participation.

CONDITIONS

Brief Title

A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell Carcinoma

Research Team

L

Lin Ma

C

Cong Wen

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here